ERS statement: A core outcome set for clinical trials evaluating the management of COPD exacerbations

- Mathioudakis, Alexander G., Abroug, Fekri, Cadus, Cordula, Coleman, Courtney, Contoli, Marco, Corlateanu, Alexandru, Corlateanu, Olga, Criner, Gerard J., Csoma, Balazs, Emelyanov, Alexander, Faner, Rosa, Fernandez Romero, Gustavo, Agusti, Alvar, McDonald, Vanessa M., Horváth, P, Huerta Garcia, A, Jacobs, M, Jenkins, C, Joos, G, Kharevich, O, Kostikas, K, Lapteva, E, Lazar, Z, Ananth, Sachin, Leuppi, JD, Liddle, C, Linnell, J, López-Giraldo, A, McDonald, VM, Nielsen, R, Papi, A, Saraiva, I, Sergeeva, G, Sioutkou, A, Bakke, Per, Sivapalan, P, Stovold, E, Wang, H, Wen, F, Yorke, J, Williamson, PR, Vestbo, J, Jensen, J-U, DECODE-NET,, Bartziokas, Konstantinos, Beghe, Bianca, Bikov, Andras, Bradbury, Thomas, Brusselle, Guy

Blood interferon-a levels and severity, outcomes, and inflammatory profiles in hospitalized COVID-19 patients

- Contoli, Marco, Papi, Alberto, Tomassetti, Luca, Rizzo, Paola, Vieceli Dalla Sega, Francesco, Fortini, Francesca, Torsani, Francesca, Morandi, Luca, Ronzoni, Luca, Zucchetti, Ottavio, Pavasini, Rita, Fogagnolo, Alberto, Volta, Carlo Alberto, Bartlett, Nathan W., Johnston, Sebastian L., Spadaro, Savino, Campo, Gianluca